Skip to main content
. 2020 Oct;146(4):840–850.e7. doi: 10.1016/j.jaci.2020.03.021

Table II.

Counts of phenotype of inflammatory cells infiltrating in epithelial and subepithelial areas in bronchial mucosa of subjects with COPD and control subjects

Groups COPD
Healthy smokers
Healthy nonsmokers
Baseline (N = 17) Day 7 (N = 17) Week 6 (N = 11) Baseline (N = 20) Day 7 (N = 20) Week 6 (N = 12) Baseline (N = 11) Day 7 (N = 11)
Epi
 Neutrophil elastase+ 4 (1-18) 8 (1-46) 14 (2-47) 3 (0-30) 8 (0-36) 10 (0-47) 4 (16-0.4) 4 (0-24)
 EG2+ 0 (0-6) 0.4 (0-11) 0.4 (0-12) 0.2 (0-8) 0.4 (0-31) 0.3 (0-5) 0 (0-19) 0.7 (0-68)
 Tryptase+ 3 (0-16) 3 (0-8) 4 (0-14) 3 (0-35) 3 (0-21) 11 (0-25) 2 (0-9) 3 (0-16)
 CD68+ 11 (1-61) 18 (1-86) 31 (4-56) 15 (1-51) 24 (5-88) 13 (0-77) 8 (3-27) 14 (4-22)
 CD4+ 3 (0-14) 8 (0-96) 5 (2-70) 3 (0-13) 6§ (1-39) 2 (0-18) 4 (0-11) 8 (2-44)
 CD8+ 55 (31-183) 67 (27-178) 94 (39-253) 67 (7-187) 72 (30-165) 73 (20-116) 38 (9-72) 321 (15-96)
 CD20+ 0 (0-0.3) 1 (0-19) 0 (0-2) 0 (0-3) 2 (0-5) 0 (0-4) 0 (0-2) 0.5 (0-6)
Sub
 Neutrophil elastase+ 109 (40-337) 135 (64-445) 155 (72-201) 135 (22-492) 148 (27-564) 117 (18-289) 125 (44-295) 149 (67-469)
 EG2+ 11 (0-87) 72 (11-349) 23 (2-169) 11 (0-66) 25 (1-257) 34 (0-199) 12 (0-66) 38 (1-176)
 Tryptase+ 301 (119-480) 220 (72-347) 184 (140-323) 341 (73-661) 220 (77-576) 300 (15-605) 310 (109-531) 248 (61-459)
 CD68+ 201 (95-388) 334 (61-603) 228 (138-379) 234 (55-633) 302 (97-883) 217 (125-506) 127 (102-182) 294 (161-559)
 CD4+ 66 (37-296) 221 (12-666) 167 (75-406) 142 (14-251) 226 (36-1014) 83 (29-447) 199 (67-293) 230 (32-342)
 CD8+ 243 (142-816) 429 (148-1003) 408 (311-593) 376 (90-910) 491 (117-1420) 541 (31-736) 159 (63-278) 236 (163-533)
 CD20+ 9 (2-44) 23 (4-270) 13 (6-138) 9 (0-39) 29 (0-406) 16 (0-51) 18 (5-46) 20 (9-215)

Values are medians (ranges) of positive cell counts per 0.1 mm2 epi and per mm2 sub.

P = .0005-.044 vs their own baselines, respectively.

P = .011-.049 vs nonsmoker day 7, respectively.

§

P = .031 vs its own week 6.

P = .0005-0.047 vs nonsmoker baseline.